POINT BIOPHARMA GLOBAL INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•] Subordinated Debt SecuritiesIndenture • July 1st, 2022 • POINT Biopharma Global Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [•], among POINT BIOPHARMA GLOBAL INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
POINT BIOPHARMA GLOBAL INC. EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • July 1st, 2022 • POINT Biopharma Global Inc. • Pharmaceutical preparations • New York
As further set forth in this agreement (this “Agreement”), POINT Biopharma Global Inc., a company organized under the laws of Delaware (the “Company”), proposes to issue and sell from time to time through Piper Sandler & Co. (the “Agent”), as sales agent, the Company’s common stock, par value $0.0001 per share (the “Common Stock”) (such shares of Common Stock to be sold pursuant to this Agreement, the “Shares”) on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.
